Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : N::A symbols : ONCY save search
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-07 (Crawled : 21:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.88%
H: 4.67%
C: -1.87%
biotech year financial results
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published: 2024-03-05 (Crawled : 12:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 6.52%
H: 6.12%
C: 5.1%
biotech cancer pancreatic
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published: 2023-11-03 (Crawled : 16:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech positive
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-03 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech financial results
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
success cancer study
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
positive cancer pancreatic study
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published: 2023-10-20 (Crawled : 14:30) - prnewswire.com
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
MYGN | News F | $18.66 -1.37% -1.39% 550K
|
Health Technology
|
| O: 0.41%
H: 3.13%
C: 2.38%
ILMN | $118.305 0.52% 0.52% 1.9M
|
Health Technology
|
| O: 0.02%
H: 0.94%
C: -0.3%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -1.46%
H: 0.48%
C: -1.06%
companies biotech cancer pancreatic treatment research
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
biotech conference financial results
Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023
Published: 2023-10-16 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.61%
H: 1.59%
C: -3.17%
biotech study
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published: 2023-10-13 (Crawled : 13:00) - prnewswire.com
PYXS | $4.845 3.31% 3.2% 570K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 2.56%
C: 2.56%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.63%
H: 4.97%
C: 2.76%
MRUS | $41.01 1.74% 1.71% 410K
|
Health Technology
|
| O: 0.47%
H: 1.7%
C: -0.38%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -0.59%
H: 0.62%
C: -0.56%
fda year review cancer pancreatic
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS
Published: 2023-09-26 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 5.63%
C: 4.69%
biotech award cancer pancreatic network
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published: 2023-09-19 (Crawled : 17:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.47%
H: 4.98%
C: 3.98%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.13%
H: 2.0%
C: 1.83%
MACK 4 | $14.68 0.0% 100K
|
Health Technology
|
| O: -0.41%
H: 0.9%
C: 0.74%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 0.03%
H: 2.18%
C: 1.8%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.01%
H: 1.99%
C: 1.28%
cancer pancreatic
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights
Published: 2023-08-14 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -3.67%
H: 0.95%
C: -2.38%
biotech financial results
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
Published: 2023-08-04 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
biotech conference financial results
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference
Published: 2023-08-04 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
biotech conference growth
Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate
Published: 2023-06-05 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.74%
H: 2.96%
C: -2.96%
biotech breast cancer trial response show
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations
Published: 2023-05-26 (Crawled : 15:00) - prnewswire.com
DAWN 4 | $14.87 1.78% 1.75% 800K
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 4.21%
C: 3.06%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -18.22%
LEGN | $48.84 -2.55% -2.62% 1.4M
|
Health Technology
|
| O: 0.35%
H: 0.63%
C: -0.58%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.07%
H: 2.53%
C: 1.23%
GILD | $66.94 -0.55% -0.55% 5.3M
|
Health Technology
|
| O: 0.45%
H: 0.79%
C: -1.17%
asco
Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract
Published: 2023-05-25 (Crawled : 22:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -18.22%
biotech breast asco positive cancer meeting trial
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Published: 2023-05-10 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 1.84%
C: 0.0%
biotech meeting results
Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights
Published: 2023-05-05 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.69%
H: 13.19%
C: 11.11%
biotech financial results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.